These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 14517390)

  • 21. Antitumor effects of thalidomide analogs in human prostate cancer xenografts implanted in immunodeficient mice.
    Ng SS; MacPherson GR; Gütschow M; Eger K; Figg WD
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4192-7. PubMed ID: 15217957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAI.
    Kohn EC; Felder CC; Jacobs W; Holmes KA; Day A; Freer R; Liotta LA
    Cancer Res; 1994 Feb; 54(4):935-42. PubMed ID: 8313384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Angiogenesis and anti-angiogenic strategies for glioblastoma].
    de Boüard S; Guillamo JS
    Bull Cancer; 2005 Apr; 92(4):360-72. PubMed ID: 15888393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of thalidomide on the expression of angiogenesis growth factors in human A549 lung adenocarcinoma cells.
    Li X; Liu X; Wang J; Wang Z; Jiang W; Reed E; Zhang Y; Liu Y; Li QQ
    Int J Mol Med; 2003 Jun; 11(6):785-90. PubMed ID: 12736723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiogenesis inhibitors in prostate cancer therapy.
    Yu EM; Jain M; Aragon-Ching JB
    Discov Med; 2010 Dec; 10(55):521-30. PubMed ID: 21189223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging role of apelin as a therapeutic target in cancer: a patent review.
    Rayalam S; Della-Fera MA; Kasser T; Warren W; Baile CA
    Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):367-72. PubMed ID: 21612576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting angiogenesis in head and neck cancer.
    Seiwert TY; Cohen EE
    Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carboxyamido-triazole induces apoptosis in bovine aortic endothelial and human glioma cells.
    Ge S; Rempel SA; Divine G; Mikkelsen T
    Clin Cancer Res; 2000 Apr; 6(4):1248-54. PubMed ID: 10778947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of angiogenesis by vitamin D-binding protein: characterization of anti-endothelial activity of DBP-maf.
    Kalkunte S; Brard L; Granai CO; Swamy N
    Angiogenesis; 2005; 8(4):349-60. PubMed ID: 16400520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis.
    Winters ME; Mehta AI; Petricoin EF; Kohn EC; Liotta LA
    Cancer Res; 2005 May; 65(9):3853-60. PubMed ID: 15867384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of angiogenesis: treatment options for patients with metastatic prostate cancer.
    Figg WD; Kruger EA; Price DK; Kim S; Dahut WD
    Invest New Drugs; 2002 May; 20(2):183-94. PubMed ID: 12099578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of angiogenesis in liver metastases by carboxyamidotriazole (CAI).
    Luzzi KJ; Varghese HJ; MacDonald IC; Schmidt EE; Kohn EC; Morris VL; Marshall KE; Chambers AF; Groom AC
    Angiogenesis; 1998; 2(4):373-9. PubMed ID: 14517457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revision of the concept of anti-angiogenesis and its applications in tumor treatment.
    Yang WH; Xu J; Mu JB; Xie J
    Chronic Dis Transl Med; 2017 Mar; 3(1):33-40. PubMed ID: 29063054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergy Between Low Dose Metronomic Chemotherapy and the pH-centered Approach Against Cancer.
    Koltai T; Cardone RA; Reshkin SJ
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic Effects of a Novel Phenylphthalimide Analog for Corneal Neovascularization and Retinal Vascular Leakage.
    Wang B; Li PK; Ma JX; Chen D
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3630-3642. PubMed ID: 30029250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase 1 study of AS1409, a novel antibody-cytokine fusion protein, in patients with malignant melanoma or renal cell carcinoma.
    Rudman SM; Jameson MB; McKeage MJ; Savage P; Jodrell DI; Harries M; Acton G; Erlandsson F; Spicer JF
    Clin Cancer Res; 2011 Apr; 17(7):1998-2005. PubMed ID: 21447719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides.
    Yue PY; Mak NK; Cheng YK; Leung KW; Ng TB; Fan DT; Yeung HW; Wong RN
    Chin Med; 2007 May; 2():6. PubMed ID: 17502003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thalidomide for treating metastatic hepatocellular carcinoma: a pilot study.
    Han SH; Park SH; Kim JH; Lee JJ; Kwon SY; Kwon OS; Kim SS; Kim JH; Kim KK; Park YH; Lee JN; Nam E; Bang SM; Cho EK; Shin DB; Lee JH
    Korean J Intern Med; 2006 Dec; 21(4):225-9. PubMed ID: 17249503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. huBC1-IL12, an immunocytokine which targets EDB-containing oncofetal fibronectin in tumors and tumor vasculature, shows potent anti-tumor activity in human tumor models.
    Lo KM; Lan Y; Lauder S; Zhang J; Brunkhorst B; Qin G; Verma R; Courtenay-Luck N; Gillies SD
    Cancer Immunol Immunother; 2007 Apr; 56(4):447-57. PubMed ID: 16874486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.